Meropenem/Vaborbactam IV
Permitted indications
Only on the advice of a Medical Microbiologist or Infection Specialist for the following indication where alternative options have been considered:
1. Treatment of adults with confirmed carbapenem-resistant Enterbacteriaceae (CRE), which is involved in the production of Klebsiella pneumoniae carbapenemase (KPC) associated with complicated urinary tract infection (including acute pyelonephritis), complicated intra-abdominal infection, hospital acquired pneumonia (including ventilator associated pneumonia) and bacteraemia that occurs in association with, or is suspected to be associated with any of the infections previously mentioned.
Not licensed for use in children.
Wards stocked
Only 24 hour supply of meropenem/vaborbactam stocked at ARI - please contact your ward pharmacist as soon as possible if this is required.